News

Arcutis Biotherapeutics Announces Key Coverage for Zoryve Cream

1 Mins read

Arcutis Biotherapeutics has recently revealed a significant development regarding its Zoryve roflumilast cream 0.3% for the treatment of plaque psoriasis. The company announced that the cream is now covered as a preferred tier product on CVS Caremark’s largest national commercial formularies. This update is effective from July 5.

Access to Millions of Additional Lives

With this latest development, Arcutis Biotherapeutics estimates that the inclusion of Zoryve on CVS Caremark’s national formularies will provide access to an additional 20 million commercial lives in the United States. This broadens the reach and availability of the treatment for individuals suffering from plaque psoriasis.

Specific Coverage Criteria

Arcutis informs that Zoryve is covered for individuals with plaque psoriasis who have a prior history of using a topical steroid. However, for individuals with plaque psoriasis in sensitive skin areas, no prior steroid therapy is required.

A Strong Leap for Arcutis Biotherapeutics

Frank Watanabe, the President and CEO of Arcutis, expressed his enthusiasm for this significant milestone. He mentioned that CVS Caremark is the largest U.S. pharmacy benefit manager to include Zoryve on its national formularies, and the third one to do so since the product’s launch less than a year ago.

Available by Prescription Only

It’s important to note that Zoryve cream is only available by prescription. Patients should consult their healthcare providers to determine if this treatment is suitable for their condition.

For further inquiries, please contact Arcutis Biotherapeutics directly.

Related posts
News

The Largest Deal of the Year: BlackRock Acquires TechBerry

1 Mins read
BlackRock is concluding its acquisition of TechBerry, which has already been named one of the largest deals of the year. The substantial…
News

Government Matching Contribution for Retirement Savings

2 Mins read
According to researchers, nearly 22 million Americans are set to benefit from a new government matching contribution initiative aimed at enhancing retirement…
News

Oil Market Update

1 Mins read
Oil Market Update On Tuesday, crude oil futures prices were lower, while refined product contracts were experiencing a second consecutive day of…

Leave a Reply

Your email address will not be published. Required fields are marked *